Scheduling changes on the agenda

New proposals may see pharmacists dispensing downscheduled allergic rhinitis, migraine treatments, while caffeine powders are to be effectively banned The TGA's medicine scheduling committee is set to rule on proposals to downschedule the migraine treatment Zolmitriptan and the allergic rhinitis drug Mometasone. Both medicines will move largely to Schedule 3 (Pharmacist Only) if the changes